The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment.
Mallikarjuna Siraganahalli EshwaraiahAparna GundaGovind Babu KanakasettyManjiri M BakrePublished in: Cancer medicine (2023)
CAB provided superior prognostic information in various Ki67 subgroups, especially in the intermediate Ki67 group.